An increase in total AFP concentration in the serum was originally used as an indicator for hepatocellular carcinoma (HCC); however, measuring the total AFP concentration cannot always discriminate between small HCCs and chronic liver disease. This evidence concerns the gene AFP and hepatocellular carcinoma.